SAB Biotherapeutics (SABS) Invested Capital (2020 - 2025)
SAB Biotherapeutics' Invested Capital came in at $151.5 million for Q4 2025, up 477.2% from $26.25 million a year earlier but down 8.2% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Invested Capital (2020 - 2025) Analysis & Trends
Going back to Q4 2020, SAB Biotherapeutics' Invested Capital data covers 18 quarters.
- Invested Capital carries a five-year compound annual growth rate of 30.7% (FY2020 to FY2025).
- Going back by year, Invested Capital was $26.25 million in FY2024 (-55.0%), $58.35 million in FY2023 (+80.2%), $32.37 million in FY2022 (-19.8%) and $40.35 million in FY2021 (+1.6%).
- The five-year range for quarterly Invested Capital is $12.02 million (Q2 2025) to $165.07 million (Q3 2025).
- Year-over-year, Invested Capital increased in five of the last eight quarters, with growth averaging 127.6%.
- The fastest year-over-year change in Invested Capital over five years came in Q4 2025 (growth of 477.2%), and the weakest in Q2 2025 (a decline of 74.3%).
- Business Quant data shows SABS's Invested Capital at $165.07 million (Q3 2025), $12.02 million (Q2 2025) and $21.55 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 134.01 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 95.89 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 79.44 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.26 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 68.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 38.08 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 148.69 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | SAB Biotherapeutics | 264.67 Mn | 264.67 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 151.50 Mn |
| Sep 30, 2025 | 165.07 Mn |
| Jun 30, 2025 | 12.02 Mn |
| Mar 31, 2025 | 21.55 Mn |
| Dec 31, 2024 | 26.25 Mn |
| Sep 30, 2024 | 36.90 Mn |
| Jun 30, 2024 | 46.74 Mn |
| Mar 31, 2024 | 53.66 Mn |
| Dec 31, 2023 | 58.35 Mn |
| Sep 30, 2023 | 15.80 Mn |
| Jun 30, 2023 | 19.83 Mn |
| Mar 31, 2023 | 24.85 Mn |
| Dec 31, 2022 | 32.37 Mn |
| Sep 30, 2022 | 30.65 Mn |
| Jun 30, 2022 | 37.40 Mn |
| Mar 31, 2022 | 42.30 Mn |
| Dec 31, 2021 | 40.35 Mn |
| Dec 31, 2020 | 39.72 Mn |
API Access
SAB Biotherapeutics Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();